Tumor markers in squamous cell carcinoma of the head and neck: Clinical effectiveness and prognostic value

European Archives of Oto-Rhino-Laryngology

Volumn 258, Issue 2, 2001, Pages 83-88

  Tannapfel, Andrea ^a   Weber, Anette ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Head and neck cancer; Molecular pathology; Prognosis; Tumor marker; Tumor stage

Indexed keywords

AUTOANTIBODY; CYTOKERATIN; FERRITIN; TUMOR MARKER;

ARTICLE; CANCER STAGING; DIAGNOSTIC ACCURACY; FOLLOW UP; GENETIC MARKER; HEAD AND NECK CANCER; HUMAN; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIOIMMUNOASSAY; SQUAMOUS CELL CARCINOMA; TISSUE SPECIFICITY; TREATMENT PLANNING; TUMOR DIAGNOSIS; TUMOR RECURRENCE;

AUTOANTIBODIES; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; GENES, ERBB-2; GENES, P53; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; POINT MUTATION; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0035118686     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004050000303     Document Type: Article

References (40)

1. The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma
2. Oxygenation status of squamous cell carcinoma of the head and neck: Comparison of primary tumors, their neck node metastases and normal tissue
3. Immumohistochemical study of the expression of human chorionic gonadotropin-beta in oral squamous cell carcinoma
4. Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis
5. Telomerase activity is upregulated in laryngeal squamous cell carcinoma
6. Influence of p53 and bcl-2 on proliferative activity and treatment outcome in head and neck cancer patients
7. P53 auto-antibodies in the sera of patients with oral squamous cell carcinoma
8. High incidence of p53 mutations in primary and metastatic head and neck tumors. Frequent protein overexpression in normal epithelium
9. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival
10. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer
11. A new prognostic indicator for head and neck cancer-p53 serum antibodies?
12. Concentration of free hCGbeta subunit in serum as a prognostic marker for squamous cell carcinoma of the oral cavity and oropharynx
13. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy
14. Detection of telomerase activity in esophageal squamous cell carcinoma and normal esophageal epithelium
15. Prognostic factors in tongue cancer - Relative importance of demographic, clinical and histopathological factors
16. Epidermal growth factor receptor (EGFR) in oral squamous cell carcinomas: Overexpression, localization and therapeutic implications
17. Beta- and gamma-catenin expression in oral squamous cell carcinomas
18. Clinical implications of screening p53 gene mutations in head and neck squamous cell carcinomas
19. Antibody formation to cellular p53 protein in patients with squamous cell carcinomas of the upper respiratory and digestive system
20. Telomerase activity in oral cancer
21. Clinical application of proliferating cell nuclear antigen, oncoprotein p53 and tumor front grading analysis in patients operated on for laryngeal cancer
22. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: Prognostic implications
23. Comparison of tumor markers in patients with squamous cell carcinoma of the head and neck
24. Molecular assessment of p53 abnormalities at the invasive front of oral squamous cell carcinomas
25. Heat-stable alkaline phosphatase. A putative tumor marker of head and neck squamous cell carcinoma
26. P53 overexpression in head and neck squamous cell carcinoma: Review of the literature
27. Gene amplification and overexpression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck
28. Characterization, quantification and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas
29. P53 expressions: Predicting recurrence and second primary tumors in head and neck squamous cell carcinoma
30. Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity
31. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma
32. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of mouth
33. Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas
34. Squamous cell carcinoma of the head and neck
35. Cytokeratin fragment 19 and squamous cell carcinoma antigen for early prediction of recurrence of squamous cell lung carcinoma
36. Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA and TPS) in patients without evidence of neoplasia
37. Patterns of chromosomal aberrations in metastasizing and nonmetastasizing squamous cell carcinomas of the oropharynx and hypopharynx
38. c-Abl expression in oral squamous cell carcinomas
39. Telomerase hTR and hTRT gene expression in oral precancerous lesions and squamous cell carcinomas